CClinicalTrials.gg
Status unknownNCT00991484Updated Oct 13, 2010

Collagen Analysis and Genetic Analysis of Families With Tendency to Hernias

An observational study in Hernia, sponsored by Herlev Hospital. Status unknown at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-10-13.

Sponsored by Herlev Hospital · Observational

The sponsor has not verified this record recently (last verified Oct 2010), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Family-based
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

Analysis of collagen subtype subcutaneously and genetic analysis of patients from families with a tendency to hernias. Furthermore circulating biomarkers and biomarkers extracted from the subcutaneously tissue such as MMP's (matrix metallo proteinases) and TIMP's (tissue inhibitor of metallo proteinases) will be measured.

Read the detailed description

Research has shown relationship between hernias and collagen subtype I/III ratio, biomarkers such as MMP's TIMP's and other diseases such as Ehlers-Danlos, Marfans syndrome, AAA (abdominal aortic aneurysms), diverticulosis and rectal prolapse. Furthermore has research raised hypothesis about inheritance of hernias. The investigators are performing genetic examination combined with analysis of collagen and biomarkers on patients belonging to families with tendency to hernias.

Other examinations performed on the patients enrolled in this study:

  • Ultrasound (US) examination of the abdominal aorta to discover possible abdominal aortic aneurysms.
  • Beightons score to evaluate the degree of joint hypermobility.
02

Conditions studied

  • Hernia

Browse trials for

Keywords

  • ventral
  • inguinal
  • hernia
  • inheritance
  • genetics
03

In context

Hernia

1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.

This study's planned enrollment of 60 is below the median of 120 across 327 observational studies indexed under Hernia.

Browse Hernia studies →

Lead sponsor

Herlev Hospital is the lead sponsor of 195 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

patients in Denmark operated or diagnosed with hernias who are member of a family with tendency to hernias.

Inclusion criteria

  • adults over 18 years
  • adults must be members of a family where there are presence of hernias in minimum generation.

Exclusion criteria

Exclusion Criteria:

  • infections
  • pregnant
  • mentally ill patients
05

Study design

Observational model
Family-based
Time perspective
Prospective
Enrollment
60 participants (estimated)
Biospecimen retention
Samples with dna

Groups and cohorts

  • control group
  • individuals from hernia-family
06

What researchers measure

Primary outcomes

  1. Expression of collagen-genes or other relevant genes by microarray analysis compared with presence of hernia

    Time frame: 1 year

Secondary outcomes

  1. Amount of collagen subtypes measured subcutaneously.

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Herlev Hospital
    DK-2730, Herlev, Herlev 2730, Denmark
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00991484
Lead sponsor
Herlev Hospital
First posted
Oct 8, 2009
Start date
Dec 2009
Primary completion
Dec 2010 (estimated)
Completion
Jun 2011 (estimated)
Last update
Oct 13, 2010

Study contacts

Jakob Burcharth, MD
Contact
jakobburcharth@gmail.com
0045 44884488 ext. 89434
Jacob Rosenberg, Prof. MD
study director · Herlev Hospital
Jakob Burcharth, MD
principal investigator · Herlev Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion